in care facilities & at home
1/3 of seniors die with/of dementia in the US
Existing cognitive therapies
provided by occupational therapists
SenopiMed makes it easy to provide
cognitive therapies, using virtual reality (VR)
Developed and validated with and for healthcare professionals.
VR Headset app
Easy-to-use VR therapies
Customized user difficulty
Ongoing clinical trial for SenopiMed (n=200)
Enjoyable & easy-to-use
Turn on the VR headset and select preferred environment and music. SenopiMed is ready for an enjoyable 12-minute therapy.
With the SenopiMed app, the completed VR therapies can be seen on your smartphone or desktop.
SenopiMed is developed and tested with healthcare professionals
SenopiMed has been under development since 2018, when it was first developed in the innovation lab of Ricola. The product has been developed with medical doctors and therapists and it has been tested in numerous usability studies.
Clinical trial commenced in April 2022 (n=200).
Aug-21 to Feb-22
Structured usability studies with 10-20 seniors and different versions of SenopiMed and SenopiPhy .
Tested SenopiMed with a group of cognitive therapists, occupational therapists and neuropsychologists.
Pilot test with SenopiCare for healthy seniors and with memory disorders with promising results.
Want SenopiVR at your
Our first product, SenopiCare,
allows seniors to travel virtually to familiar and new places places.
The easy-to-use tablet application allows a caregiver to select the preferred 360-degrees videos and start a VR experience for
one or multiple seniors.
SenopiVR is a Swiss MedTech start-up founded in 2019 and a spinoff of Ricola’s Innovation lab, Ricolab.
The company is on a mission to improve seniors’ quality of life and cognitive function using virtual reality (VR).
Karsten Kure Bagger
CEO & Co-founder
VP Sales & Partnerships
VP Product & Business Development
Dr. Javier Oltra